Silk fibroin-based embolic agent for transhepatic artery embolization with multiple therapeutic potentials

Linlin Shi,Danni Li,Qianqian Tong,Guorong Jia,Xiaohong Li,Lan Zhang,Qingqing Han,Rou Li,Changjing Zuo,Wei Zhang,Xiao Li
DOI: https://doi.org/10.1186/s12951-023-02032-9
IF: 10.2
2023-08-21
Journal of Nanobiotechnology
Abstract:The excellent physicochemical and biomedical properties make silk fibroin (SF) suitable for the development of biomedical materials. In this research, the silk fibroin microspheres (SFMS) were customized in two size ranges, and then carried gold nanoparticles or doxorubicin to evaluate the performance of drug loading and releasing. Embolization efficiency was evaluated in rat caudal artery and rabbit auricular artery, and the in vivo distribution of iodinated SFMS ( 125 I/ 131 I-SFMS) after embolization of rat hepatic artery was dynamically recorded by SPECT. Transhepatic arterial radioembolization (TARE) with 131 I-SFMS was performed on rat models with liver cancer. The whole procedure of selective internal radiation was recorded with SPECT/CT, and the therapeutic effects were evaluated with 18 F-FDG PET/CT. Lastly, the enzymatic degradation was recorded and followed with the evaluation of particle size on clearance of sub-micron silk fibroin.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?